![\"Logo\"](\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2025\/09\/Agenparl.png\")
(AGENPARL) – Roma, 25 Settembre 2025<\/p>\n\t\t (AGENPARL) – Roma, 25 Settembre 2025<\/p>\n
(AGENPARL) \u2013 Thu 25 September 2025 PRESS RELEASE2025-348-EN
Nicosia, 25 September 2025
EIB to provide additional financing in Cyprus to boost healthcare as well as support to EU-funded investments
Additional \u20ac5 million to complete on-going investments by the Cyprus Institute of Neurology and Genetics (CING)
\u20ac50 million to the Republic of Cyprus for its Operational Programme THALIA 2021\u20132027
Investments will improve healthcare, enhance research and education, and accelerate Cyprus\u2019s green and digital transition
With these agreements, the European Investment Bank (EIB) today increases its total financing to Cyprus, confirming its strong partnership with the country and long term commitment to invest in people and communities.
Cyprus Institute of Neurology and Genetics R&D
The first agreement concerns the \u20ac5m additional financing to the Cyprus Institute of Neurology and Genetics (CING), bringing total support to \u20ac31 million. The operation will:
support the construction of CING\u2019s new facilities,
refurbishment of the current premises,
provide advanced medical and laboratory equipment, including genomics, proteomics, microscopes, bioinformatics tools and a biobank,
support R&D activities and research projects
strengthen postgraduate education and training.
These investments will reinforce CING\u2019s role as a regional and international centre of excellence, improving treatment for patients with rare and neurological diseases, enhancing research capacity and securing its competitiveness in attracting international research funding.
Cyprus EU Funds Co-financing 2021-2027
The second \u20ac50m agreement with the Republic of Cyprus concerns the support of Cyprus National Contribution to the EU co-financed Operational Programme THALIA 2021\u20132027. The total programme cost is close to \u20ac1.5 billion out of which EIB loan has so far provided \u20ac180m of an approved amount of \u20ac369m. As the country\u2019s main development programme, THALIA focuses on smart, green and inclusive growth. EIB financing will back projects including:
upgrades to energy and water efficiency infrastructure in municipalities,
modernisation of education and training facilities,
expansion of digital public services,
projects strengthening environmental sustainability and climate resilience.
These investments will help drive Cyprus\u2019s green and digital transition, promote balanced regional development and strengthen social cohesion.
Vice-President Kyriacos Kakouris, stated: \u201cToday\u2019s agreements demonstrate once again the \u2019s strong partnership with Cyprus. In particular, I would like to highlight our valuable support to CING, for improving and upgrading its medical research and healthcare and that will benefit patients with sensitive neurological and genetic medical needs. CING\u2019s new premises are expected to be ready before the end of the year. In addition, through the THALIA programme, we are backing smart, green and inclusive growth across the country. Together, these investments will strengthen Cyprus\u2019s resilience and future competitiveness.\u201d
These agreements build on the EIB\u2019s long-standing cooperation with Cyprus, supporting high value-added investments in healthcare, education, innovation, infrastructure and climate action.
The Minister of Finance of the Republic of Cyprus, said: \u201cToday marks another milestone in the long-standing cooperation between Cyprus and the European Investment Bank. Through the EIB\u2019s support for the \u201cTHALEIA 2021\u20132027\u201d Programme, green, innovative, and socially inclusive development is being promoted, enhancing competitiveness, social cohesion, and the quality of life for citizens. At the same time, the additional financing for the Cyprus Institute of Neurology and Genetics will support the completion of new facilities, the renovation of existing spaces, and the strengthening of research capacities, reinforcing the Institute\u2019s role as a centre of excellence in Cyprus and internationally.\u201d
About CING:
Founded in 1990 by the Cyprus Foundation for Muscular Dystrophy Research, CING is a bi-communal, non-profit medical, research and academic centre. It is the only specialised tertiary healthcare provider in Cyprus in neurology and medical genetics, offering services free of charge at the point of delivery to all citizens regardless of religion or ethnic origin. The Institute conducts cutting-edge translational research on rare and neurological diseases, supports postgraduate education, and maintains international collaborations, contributing significantly to Cyprus\u2019 scientific and medical research capacity.
Professor Leonidas Phylactou, Chief Executive Officer & Medical Director of the Cyprus Institute of Neurology and Genetics, said: \u201cWe are deeply grateful for the trust of the European Investment Bank. We are also thankful to the Ministry of Finance for its continuous support and for financing this vital project, as well as the Deputy Ministry of Research, Innovation and Digital Policy for its continuous support of our activities. This support is, above all, an investment in people. It empowers CING to fulfil its mission as a centre of excellence in healthcare, research and education, and to contribute to the advancement of medical science at both the national and international level. At CING, our mission is to improve lives, and today\u2019s agreement brings us one step closer to that goal.\u201d
About \u201cTHALIA 2021-2027\u201d
Operational Programme \u201cTHALIA 2021\u20132027\u201d, the EU-funded programme supports Cyprus\u2019s development priorities and aligns with EU cohesion policy goals. It includes investments in research and innovation, digitalisation, sustainable mobility, energy efficiency, renewable energy, water infrastructure and social inclusion, contributing to balanced socioeconomic and regional development.
Mrs. Anthi Philippidou, Director of EU Cohesion Policy and Multiannual Financial Framework, DG Growth, Ministry of Finance, stated: \u201cThe longstanding and fruitful partnership with the European Investment Bank has played a vital role in supporting Cyprus\u2019 efforts to implement its Cohesion Policy Programmes. The funding secured for the \u2018THALIA2021-2027\u2019 programme carries particular importance at this stage, as Cyprus\u2019 co-financing obligations have increased in line with the robust growth of the national economy. The signing of this financing agreement marks a pivotal milestone in the programme\u2019s implementation, which is instrumental in driving growth, creating jobs, and fostering social cohesion.\u201d
Background information
About EIB
The European Investment Bank (ElB) is the long-term lending institution of the European Union, owned by its Member States. The finances investments in eight core priorities that support EU policy objectives: climate action and the environment, digitalisation and technological innovation, security and defence, cohesion, agriculture and the bioeconomy, social infrastructure, a stronger Europe in a more peaceful and prosperous world and Europe\u2019s capital markets union.\u202f\u202f\u00a0
The EIB Group, which also includes the European Investment Fund (EIF), signed nearly \u20ac89\u00a0billion in new financing for over 900 high-impact projects in 2024, boosting Europe\u2019s competitiveness and security.
Approximately half of the EIB\u2019s financing within the EU targets cohesion regions, where per-capita income is below the EU average, while almost 60% of annual EIB Group investments support climate action and environmental sustainability.\u00a0
Since the first operation in 1981, the EIBG Group has invested over \u20ac5.5 billion in Cyprus and remains a key partner in the country\u2019s sustainable growth\u2014 further underlined by strengthening its local presence and leadership. The bank\u2019s priority sectors in Cyprus are energy security, affordable housing, SMEs and innovation, water and climate resilience.
Read more about the Group\u2019s activities in Cyprus here.
Press contacts
\u00a0\u00a0\u00a0 \u00a0\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"(AGENPARL) – Roma, 25 Settembre 2025 (AGENPARL) \u2013 Thu 25 September 2025 PRESS RELEASE2025-348-ENNicosia, 25 September 2025EIB to…\n","protected":false},"author":2,"featured_media":180594,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[50],"tags":[200,79],"class_list":["post-180593","post","type-post","status-publish","format-standard","has-post-thumbnail","category-genetics","tag-genetics","tag-science"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/180593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=180593"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/180593\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/180594"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=180593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=180593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=180593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}